ArticleVaccines2025

Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.